Vera Therapeutics, Inc. (VERA)
37.32
-2.24
(-5.66%)
USD |
NASDAQ |
May 15, 16:00
37.33
+0.01
(+0.03%)
After-Hours: 20:00
Vera Therapeutics EPS Diluted (Quarterly) : -1.693 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.60 |
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| United Therapeutics Corp. | 5.824 |
| Biogen, Inc. | 2.153 |
| Cytokinetics, Inc. | -1.671 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -121.03M |
| Total Expenses (Quarterly) | 121.03M |
| Enterprise Value | 2.157B |
| Earnings Yield | -14.86% |
| Normalized Earnings Yield | -14.86 |